67 related articles for article (PubMed ID: 8264706)
1. Inability of insulin to maintain normal nerve function during high-frequency stimulation in diabetic rat tail nerves.
Andersen H; Nielsen JF; Nielsen VK
Muscle Nerve; 1994 Jan; 17(1):80-4. PubMed ID: 8264706
[TBL] [Abstract][Full Text] [Related]
2. Reduced capability of transmitting high frequency impulses in tail nerves of diabetic rats.
Nielsen JF; Andersen H; Nielsen VK
Muscle Nerve; 1993 Mar; 16(3):283-8. PubMed ID: 8446126
[TBL] [Abstract][Full Text] [Related]
3. Effects of the Ca2+ antagonist nimodipine on functional deficits in the peripheral and central nervous system of streptozotocin-diabetic rats.
Biessels GJ; ter Laak MP; Kamal A; Gispen WH
Brain Res; 2005 Feb; 1035(1):86-93. PubMed ID: 15713280
[TBL] [Abstract][Full Text] [Related]
4. Limits of normal nerve function during high-frequency stimulation.
Robinson LR; Nielsen VK
Muscle Nerve; 1990 Apr; 13(4):279-85. PubMed ID: 2355940
[TBL] [Abstract][Full Text] [Related]
5. Neurogenic cutaneous vasodilatation and plasma extravasation in diabetic rats: effect of insulin and nerve growth factor.
Bennett GS; Garrett NE; Diemel LT; Brain SD; Tomlinson DR
Br J Pharmacol; 1998 Aug; 124(7):1573-9. PubMed ID: 9723973
[TBL] [Abstract][Full Text] [Related]
6. Depletion of taurine in experimental diabetic neuropathy: implications for nerve metabolic, vascular, and functional deficits.
Pop-Busui R; Sullivan KA; Van Huysen C; Bayer L; Cao X; Towns R; Stevens MJ
Exp Neurol; 2001 Apr; 168(2):259-72. PubMed ID: 11259114
[TBL] [Abstract][Full Text] [Related]
7. Prolonged ischemic conduction failure after reperfusion in diabetic nerve.
Baba M; Nukada H; McMorran D; Takahashi K; Wada R; Yagihashi S
Muscle Nerve; 2006 Mar; 33(3):350-5. PubMed ID: 16320311
[TBL] [Abstract][Full Text] [Related]
8. Aminoguanidine--effects on endoneurial vasoactive nitric oxide and on motor nerve conduction velocity in control and streptozotocin-diabetic rats.
Dewhurst M; Omawari N; Tomlinson DR
Br J Pharmacol; 1997 Feb; 120(4):593-8. PubMed ID: 9051296
[TBL] [Abstract][Full Text] [Related]
9. Sensory nerve conduction of the plantar nerve compared with other nerve conduction tests in rats.
Kurokawa K; de Almeida DF; Zhang Y; Hébert CD; Page JG; Schweikart KM; Oh SJ
Clin Neurophysiol; 2004 Jul; 115(7):1677-82. PubMed ID: 15203069
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of stobadine on NCV in streptozotocin-diabetic rats: augmentation by vitamin E.
Skalska S; Kyselova Z; Gajdosikova A; Karasu C; Stefek M; Stolc S
Gen Physiol Biophys; 2008 Jun; 27(2):106-14. PubMed ID: 18645225
[TBL] [Abstract][Full Text] [Related]
11. Insulin-induced immunohistochemical and morphological changes in pancreatic beta-cells of streptozotocin-treated diabetic rats.
Adewole SO; Ojewole JA
Methods Find Exp Clin Pharmacol; 2007 Sep; 29(7):447-55. PubMed ID: 17982509
[TBL] [Abstract][Full Text] [Related]
12. Carbon disulfide neurotoxicity in rats: VI. Electrophysiological examination of caudal tail nerve compound action potentials and nerve conduction velocity.
Herr DW; Vo KT; Morgan DL; Sills RC
Neurotoxicology; 1998 Feb; 19(1):129-46. PubMed ID: 9498229
[TBL] [Abstract][Full Text] [Related]
13. Melatonin treatment protects against diabetes-induced functional and biochemical changes in rat aorta and corpus cavernosum.
Paskaloglu K; Sener G; Ayanğolu-Dülger G
Eur J Pharmacol; 2004 Sep; 499(3):345-54. PubMed ID: 15381057
[TBL] [Abstract][Full Text] [Related]
14. Neurotrophin-3 reverses nerve conduction velocity deficits in streptozotocin-diabetic rats.
Mizisin AP; Calcutt NA; Tomlinson DR; Gallagher A; Fernyhough P
J Peripher Nerv Syst; 1999; 4(3-4):211-21. PubMed ID: 10642089
[TBL] [Abstract][Full Text] [Related]
15. Impaired healing of gastric lesions in streptozotocin-induced diabetic rats: effect of basic fibroblast growth factor.
Takeuchi K; Takehara K; Tajima K; Kato S; Hirata T
J Pharmacol Exp Ther; 1997 Apr; 281(1):200-7. PubMed ID: 9103498
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal studies of time-dependent changes in both bladder and erectile function after streptozotocin-induced diabetes in Fischer 344 male rats.
Melman A; Zotova E; Kim M; Arezzo J; Davies K; DiSanto M; Tar M
BJU Int; 2009 Nov; 104(9):1292-300. PubMed ID: 19389003
[TBL] [Abstract][Full Text] [Related]
17. Depression of glucose levels and partial restoration of pancreatic beta-cell damage by melatonin in streptozotocin-induced diabetic rats.
Kanter M; Uysal H; Karaca T; Sagmanligil HO
Arch Toxicol; 2006 Jun; 80(6):362-9. PubMed ID: 16341692
[TBL] [Abstract][Full Text] [Related]
18. Effects of imidapril, an angiotensin-converting enzyme inhibitor, on insulin sensitivity and responsiveness in streptozotocin-induced diabetic rats.
Viana AY; Oshida Y; Han YQ; Koshinaka K; Sato Y
Horm Metab Res; 2004 Jan; 36(1):34-8. PubMed ID: 14983404
[TBL] [Abstract][Full Text] [Related]
19. Effect of propionyl-L-carnitine on motor nerve conduction, autonomic cardiac function, and nerve blood flow in rats with streptozotocin-induced diabetes: comparison with an aldose reductase inhibitor.
Hotta N; Koh N; Sakakibara F; Nakamura J; Hamada Y; Wakao T; Hara T; Mori K; Naruse K; Nakashima E; Sakamoto N
J Pharmacol Exp Ther; 1996 Jan; 276(1):49-55. PubMed ID: 8558455
[TBL] [Abstract][Full Text] [Related]
20. Streptozotocin induced diabetes as a model of phrenic nerve neuropathy in rats.
Rodrigues Filho OA; Fazan VP
J Neurosci Methods; 2006 Mar; 151(2):131-8. PubMed ID: 16125783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
